Marian G. Japitana Bunnell, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 906 W Carolina Ave, Hartsville, SC 29550 Phone: 843-332-6645 |
Raven V. Delgado, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 701 Medical Park Dr Ste 207, Hartsville, SC 29550 Phone: 843-383-7350 Fax: 843-332-9229 |
Dr. Solomon Budhram, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 906 W Carolina Ave, Hartsville, SC 29550 Phone: 843-332-6645 Fax: 843-332-9894 |
Dr. James Oscar Morphis, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 708 Medical Park Dr, Hartsville, SC 29550 Phone: 843-332-5121 Fax: 843-332-0993 |
Dr. Elizabeth Johnson Morphis, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 708 Medical Park Dr, Hartsville, SC 29550 Phone: 843-332-5121 Fax: 843-332-0993 |
Dr. Joni Sue Ovanna Budhram, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 701 Medical Park Dr, Suite 108, Hartsville, SC 29550 Phone: 843-332-6645 Fax: 843-332-9229 |
News Archive
Previous studies have hypothesized that low levels of the enzyme thymidylate synthase (TS) likely mark patients who will benefit from the drug pemetrexed - but results have been inconclusive at best and at times contradictory. A University of Colorado Cancer Center study recently published in the Journal of Thoracic Oncology provides an explanation why: only in combination with high levels of a second enzyme, FPGS, does low TS predict response to pemetrexed in patients with malignant pleural mesothelioma.
Migraines currently affect about 20 percent of the female population, and while these headaches are common, there are many unanswered questions surrounding this complex disease. Previous studies have linked this disorder to an increased risk of stroke and structural brain lesions, but it has remained unclear whether migraines had other negative consequences such as dementia or cognitive decline.
How about the fact that even if you choose to smoke outside of your home or only smoke in your home when your children are not there - thinking that you're keeping them away from second-hand smoke - you're still exposing them to toxins?
Cell Therapeutics, Inc. ("CTI") announced today that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology ("ASH") Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of pixantrone (the "PIX 301 EXTEND trial") in relapsed or refractory, aggressive non-Hodgkin's lymphoma ("NHL") patients who have failed 2 or more prior therapies.
A study led by the Translational Genomics Research Institute has for the first time matched dozens of infantile diseases and syndromes involving muscle weakness and stiff joints to their likely genetic origins.
› Verified 3 days ago